Cdkn1a silencing restores myoblast differentiation by inducing selective apoptosis in senescent cells.

Sujin Kim, Bonsang Gu, Chan-Young So, Keren Esther Kristina Mantik, Seung-Hyun Jung, Sohee Moon, Dong-Ho Park, Hyo-Bum Kwak, Jinkyung Cho, Eun-Jeong Cho, Jae-Seon Lee, Ju-Hee Kang

Department of Pharmacology, Inha University College of Medicine, 100, Inha-Ro, Michuhol-Gu, Incheon, 22212, Republic of Korea. · pubmed

Paper

Abstract

Sarcopenia, characterized by a progressive loss of skeletal muscle mass and function, is associated with the accumulation of senescent muscle stem cells, which impair muscle regeneration and contributes to the decline in muscle health. Cdkn1a, which encodes p21, is a well-known marker of cellular senescence. However, it remains unclear whether p21 inhibition eliminates senescent myoblasts and restores the differentiation capacity.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Silencing Cdkn1a enhances myoblast differentiation by selectively inducing apoptosis in senescent cells. This research addresses the accumulation of senescent cells, which is a root cause of sarcopenia and muscle degeneration associated with aging, thereby contributing to the understanding of mechanisms that could potentially restore muscle health in the context of longevity.

Author of this paper? Send a correction.